Tag: Biologics Market Size

Global Biologics Market Expanding at a CAGR of 8.25% during 2024-2030

MarkNtel Advisors, a leading market research firm, has showed its latest study titled “Global Biologics Market“, offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.

The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.

Analysis and Insights into the Global Biologics Market: 2024-2030

The Global Biologics Market size is valued at USD 412 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30.

Download the PDF Sample Copy (Including FULL TOC, Graphs, and Tables) of this Report – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Global Biologics Market Driver:

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

Global Biologics Market Segmentation:

The Global Biologics Market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.

By Therapeutic Application

-Oncology- Market Size & Forecast 2019-2030, (USD Million)

-Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)

-Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)

-Diabetes- Market Size & Forecast 2019-2030, (USD Million)

-Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)

-Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Drug Class

-Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)

-Hormones- Market Size & Forecast 2019-2030, (USD Million)

-Cytokines- Market Size & Forecast 2019-2030, (USD Million)

-Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)

-Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)

-Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)

-Vaccines- Market Size & Forecast 2019-2030, (USD Million)

-Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

-Microbes- Market Size & Forecast 2019-2030, (USD Million)

-Humans- Market Size & Forecast 2019-2030, (USD Million)

-Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million).

Geographical Analysis into the Global Biologics Market:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Read Detailed Index of full Research Study at – https://www.marknteladvisors.com/research-library/global-biologics-market.html

Competitive Landscape and Global Biologics Market Share Analysis:

The competitive landscape of the Global Biologics Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.

The report features major players including:

Bristol-Myers Squibb, Pfizer, Sanofi, Janssen Biotech, Inc., Bayer AG, Merck & Co., Amgen Inc., Abbott GmbH, Novartis, AstraZeneca Plc, GlaxoSmithKline Biologicals, Moderna, Inc., Ferring Pharmaceuticals Inc., Aimmune Therapeutics, Inc., F. Hoffman La Roche, and Others.

Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

  • What factors are driving the Global Biologics Market growth?
  • How is the Global Biologics Market expected to grow over the next five years?
  • What are the key insights into the current trends in the Global Biologics Market?
  • What is the current size of the Global Biologics Market, and how is it projected to change in the future?
  • What is the future outlook for the Global Biologics Market in terms of technological advancements and market expansion?

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call: 📞 +1 628 895 8081 +91 120 4278433

Email: 📧 sales@marknteladvisors.com

Visit to know more: 🌐 https://www.marknteladvisors.com

Biologics Market Trends, Share, Growth Drivers, Business Analysis and Future Investment 2026: Markntel Advisors

Comprehensive Research Report on Global Biologics Market Analysis, Growth Forecast 2021-26.

According to MarkNtel Advisors study the Global Biologics Market research report is an extensive document that includes a plethora of information, including several opportunities and dynamics that are pertinent to the 2023–2026 projection period.

The Global Biologics Market Size Analysis, 2021, the market is likely to grow at a CAGR of around 9% during 2021-26.

 “In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Competitive Landscape & Segmentation Analysis:

In order to provide a clear picture of competitive environment of the studied industry, we conducted a detailed analysis of both the major global players and the important regional small- and medium-sized businesses with significant growth potential. This global Biologics market research provides information on the competitors, including their sales volume and revenue with corresponding market shares, price, and gross margin. It also examines the current competitive situation of the market. Furthermore discussed are the market concentration ratio, mergers, acquisitions, and expansion strategies.

  • Abbive Inc.
  • Amgen Inc.
  • Hoffman La Roche
  • Samsung Electronics
  • Merck & Co.
  • AstraZenca Plc.
  • Bristol-Myers Squibb
  • Novartis
  • Pfizer
  • Sanofi

By identifying the high growth sectors, the study also gives stakeholders valuable insights into the trends and factors that are either driving or impeding the market growth possibilities. From a strategic perspective, it looks at each submarket’s unique growth trajectory and market share.

By Therapeutic Application

-Oncology

-Infectious Disease

-Autoimmune Disease

-Diabetes

-Metabolic disorders

-Inflammatory Bowel Diseases

-Respiratory Disorders

-Neurological Disorders

-Cardiovascular Disorder

-Musculoskeletal Disorders

-Ophthalmic Disorders

-Others

By Distribution channel

-Hospital Pharmacies

-Retail Pharmacies

-Online Pharmacies

By Manufacturing

-Outsource

-In-house

By Product/Drug Class

-Recombinant therapeutic Products

-Monoclonal Antibodies

-Hormones

-Cytokines

-Enzymes

-Blood and Blood Components

-Cellular and Gene Therapy

-Vaccines

-Oligonucleotides

Geographically, the Global Biologics extends across the following regions:

By Region

-North America

-South America

-Europe

-Asia-Pacific

-Middle East & Africa

Read Full Report: https://www.marknteladvisors.com/research-library/global-biologics-market.html

Key Benefits for Stakeholders:

  • To determine the prevailing market opportunities, this research offers a quantitative study of the market segments, current trends, projections, and shifts in the global Biologics market analysis from 2021 to 2026.
  • Information on the main factors driving the market as well as the obstacles and possibilities are provided.
  • The power of suppliers and buyers to empower stakeholders to make profit-driven business decisions and fortify their supplier-buyer network is underscored by Porter’s five forces analysis.
  • A comprehensive examination of the Biologics market segmentation aids in identifying the dominant market opportunities.
  • The major countries in each area are shown in relation to the revenue they generate for the global market.
  • Market player positioning makes benchmarking easier and gives a clear picture of the current market position of each participant discussed in the report.
  • The research analyzes market trends for Biologics industry on a regional and global scale, as well as the major competitors, market segments, and industry expansion tactics.

Customization Available – https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html

About us –

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call: 📞 +1 628 895 8081 +91 120 4278433

Email: 📧 sales@marknteladvisors.com

Visit to know more: 🌐 https://www.marknteladvisors.com/